Safety and Efficacy of 90Y Ibritumomab Tiuxetan (Zevalin®) for Untreated FollicularNon-Hodgkin’s Lymphoma (FL) Patients, An Italian Cooperative Study - Pica, G; Nati, S; Vitolo, U (ASH Annual Meeting Blood, 2011)
et al.